Stock 688212 SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.

Equities

688212

CNE100004ZJ5

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
55.4 CNY -0.13% Intraday chart for Shanghai AoHua Photoelectricity Endoscope Co., Ltd. +5.93% -10.69%
Feb. 26 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 72.89 times its estimated earnings per share for the ongoing year.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is not the most generous with respect to shareholders' compensation.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-10.69% 1.02B -
SARTORIUS AG Stock Sartorius AG
-12.91% 19.08B
A
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-46.21% 2.65B
C+
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+18.15% 1.87B - -
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-3.12% 1.61B -
BIOTAGE AB Stock Biotage AB
+23.78% 1.21B
B+
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-20.89% 905M -
C-
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-18.10% 682M
B+
REVENIO GROUP OYJ Stock Revenio Group Oyj
-7.14% 716M -
PHC CO.,LTD. Stock PHC Co.,Ltd.
-.--% 301M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688212 Stock
  4. Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.